文章摘要
张韶凯,赵方辉,乔友林.中国宫颈癌防治研究20年历程与成就[J].中华流行病学杂志,2020,41(6):809-812
中国宫颈癌防治研究20年历程与成就
Development and achievements regarding the prevention and control of cervical cancer in the last 20 years in China
收稿日期:2019-12-03  出版日期:2020-06-16
DOI:10.3760/cma.j.cn112338-20191203-00849
中文关键词: 宫颈癌;疫苗;筛查;预防
英文关键词: Cervical cancer;Vaccine;Screening;Prevention
基金项目:
作者单位E-mail
张韶凯 河南省癌症中心 郑州大学附属肿瘤医院 河南省肿瘤医院, 郑州 450000  
赵方辉 国家癌症中心 中国医学科学院/北京协和医学院肿瘤医院, 北京 100021  
乔友林 国家癌症中心 中国医学科学院/北京协和医学院肿瘤医院, 北京 100021 qiaoy@cicams.ac.cn 
摘要点击次数: 101
全文下载次数: 96
中文摘要:
      宫颈癌是全球女性第四大常见恶性肿瘤,我国发病人数占全球的18.6%,防控形势严峻。经过20年的探索与努力,我国形成了宫颈癌流行病学及病因学科学证据,HPV预防性疫苗取得突破进展,筛查技术日渐成熟以及初步提出适用于不同经济水平条件地区的多种宫颈癌筛查方案。尽管如此,基层卫生服务能力亟待提高,以缩小其与实际需求之间的差距,加速实现全球消除宫颈癌的宏伟目标。
英文摘要:
      Cervical cancer is the fourth common cancer in women globally, with the number of new cases accounted for 18.6% among all the cancer patients, in China. It is well known that the situation of prevention and control programs are quite challenging. Based on the efforts being made in the last 20 years, the etiology and carcinogenesis on cervical cancer had been clearly understood. Breakthroughs had been achieved in the development of prophylactic human papillomovirus vaccine and the technology of in screening. Various screening strategies are already available in areas with different economic status. Nevertheless, the capacity of health care services at the primary care clinics needs to be improved to narrow the gap between the reality and the demands.
查看全文   Html全文     查看/发表评论  下载PDF阅读器
关闭